HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate COO Cook Tapped To Succeed President Shanahan

This article was originally published in The Rose Sheet

Executive Summary

Colgate Chief Operating Officer Ian Cook will become president of the oral care company following the retirement of William Shanahan, the firm announced during an April 27 Q1 sales and earnings call. The appointment, effective in the third quarter, indicates Cook is a likely contender to succeed CEO Reuben Mark

You may also be interested in...



Colgate President Cook Slated For CEO Post After Mark’s Retirement

Colgate-Palmolive President and COO Ian Cook will take over the chief executive position after current Chairman and CEO Reuben Mark retires in 2007, according to Mark

Colgate President Cook Slated For CEO Post After Mark’s Retirement

Colgate-Palmolive President and COO Ian Cook will take over the chief executive position after current Chairman and CEO Reuben Mark retires in 2007, according to Mark

Colgate management

Chief Operating Officer Ian Cook will succeed President William Shanahan upon his retirement Sept. 30, firm reports. Colgate announced the appointment earlier this year, signaling Cook was a likely contender to replace CEO Reuben Mark, who said in 2004 he planned to step down in two to four years (1"The Rose Sheet" May 2, 2005, p. 3). Exec will retain position as COO, to which he was promoted last year. Separately, firm released Q2 results July 27. Oral care, personal care and home care sales grew 11% to $2.46 bil., and operating profit in the segment was up 4% to $527.4 mil. Q2 net sales grew 10.5% to $2.84 bil., but net income including restructuring charges fell 8% to $342.9 mil...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel